Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

AHA Statement: Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?

3 Jun, 2021 | 10:52h | UTC

Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association – Hypertension

News Release: ‘Prescription’ to sit less, move more advised for mildly high blood pressure and cholesterol – American Heart Association

Commentary: AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards – TCTMD

 

Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men.

2 Jun, 2021 | 08:37h | UTC

Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men – Science (a few articles per month are free)

Related: CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.

 

Commentary on Twitter

https://twitter.com/rfsquared/status/1399803644288061442

 

RCT: Among patient with recent ischemic stroke without known atrial fibrillation, implantable loop recorder monitoring for 12 months detects more occurrences of AF compared with conventional external loop recorder monitoring for 30 days (15.3% vs. 4.7%) – “further research is needed to compare clinical outcomes associated with these monitoring strategies”.

2 Jun, 2021 | 08:30h | UTC

Effect of Implantable vs. Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Detection of Subclinical Atrial Fibrillation After Stroke: Is There Enough Evidence to Treat? – JAMA (free for a limited period)

Commentary: Implantable device more effective at detecting atrial fibrillation than standard of care – News Medical

 

RCT: Insertable cardiac monitors used for 12 months detect more atrial fibrillation than usual care in patients with a recent ischemic stroke (12.1% vs. 1.8%) – “further research is needed to understand whether identifying AF in these patients is of clinical importance”.

2 Jun, 2021 | 08:29h | UTC

Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Detection of Subclinical Atrial Fibrillation After Stroke: Is There Enough Evidence to Treat? – JAMA (free for a limited period)

Commentary: Chip inserted under the skin may better identify patients at risk of recurrent stroke – Massachusetts General Hospital

 

M-A: After an acute coronary syndrome treated with coronary stenting, dual antiplatelet therapy (DAPT) for 1 to 3 months followed by P2Y12 inhibitor monotherapy is associated with improved outcomes compared with traditional DAPT for 12 months.

2 Jun, 2021 | 08:26h | UTC

Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting – American Journal of Medicine (link to abstract – $ for full-text)

 

Global cardiovascular organizations release joint opinion on achieving the ‘tobacco endgame’.

27 May, 2021 | 08:22h | UTC

Statement: The tobacco endgame—eradicating a worsening epidemic: a joint opinion from the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology

News release: Global cardiovascular organizations release joint opinion on achieving the ‘tobacco endgame’  – American College of Cardiology

Commentary: The Tobacco Endgame—Eradicating a Worsening Epidemic – American College of Cardiology

 

State-of-the-Art Review: Clinical approach to cardiovascular toxicity of oral antineoplastic agents

26 May, 2021 | 08:20h | UTC

Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review – Journal of the American College of Cardiology

Summary: Cardiovascular Toxicity of Oral Antineoplastic Agents – American College of Cardiology

 

CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.

24 May, 2021 | 08:41h | UTC

COVID-19 VaST Work Group Technical Report – May 17, 2021 – Centers for Disease Control and Prevention

Commentaries: C.D.C. Is Investigating a Heart Problem in a Few Young Vaccine Recipients – The New York Times AND U.S. CDC looking into heart inflammation in some young vaccine recipients – Reuters

Related: Israel said probing link between Pfizer shot and heart problem in men under 30 – The Times of Israel

 

#ACC21 – RCT: Among patients with resistant hypertension, ultrasound renal denervation resulted in a modest improvement in systolic BP (–4.5 mm Hg) vs. sham procedure.

24 May, 2021 | 08:28h | UTC

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial – The Lancet (link to abstract – $ for full-text)

Commentary: Renal Denervation for Resistant Hypertension Is Not Back on Track – “A systolic blood pressure (SBP) reduction of 4.5 mm Hg is not good enough—for an invasive procedure”. – Medscape (free registration required)

 

#ACC21 – Lessons from the ACC 2021 Meeting.

24 May, 2021 | 08:29h | UTC

Lessons from the ACC 2021 Meeting – by John Mandrola, MD

 

SPRINT Trial final report: targeting a systolic BP of less than 120 mm Hg in patients at increased CV risk is associated with improved CV and mortality outcomes but increases the risk of serious adverse events.

20 May, 2021 | 08:36h | UTC

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control – New England Journal of Medicine

Commentary: Final results of SPRINT study confirm controlling blood pressure critically important in preventing heart disease and stroke – Cleveland Medical Center

 

Global survey finds 44% of cardiologists report a hostile work environment. Higher rates were found among women (68%) vs. men (37%).

20 May, 2021 | 08:35h | UTC

Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Editorial: Hostile Work Environment: A Case of the Emperor’s New Clothes

Commentary: Hostility Is Common in Cardiology: Can a New ACC/AHA Statement Help? – TCTMD

Related: 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report – Circulation

 

Commentary on Twitter

 

ESC Comprehensive review: Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease.

20 May, 2021 | 08:26h | UTC

Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy – European Heart Journal – Cardiovascular Pharmacotherapy

 

Commentary on Twitter

 

#ACC21 – The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – “The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women”.

18 May, 2021 | 07:32h | UTC

Homepage: The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – The Lancet (free registration required)

Infographic: Women and cardiovascular disease

Video: The Lancet women and cardiovascular disease Commission

News release: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030 – The Lancet

 

Commentary on Twitter (thread – click for more)

 

#ACC21 – RCT: Clopidogrel better than aspirin for chronic maintenance monotherapy after percutaneous coronary intervention.

18 May, 2021 | 07:34h | UTC

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial – The Lancet (free registration required)

Commentaries: Harmonizing Optimal Strategy for Treatment of coronary artery diseases-EXtended Antiplatelet Monotherapy – HOST-EXAM – American College of Cardiology AND Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM – TCTMD

Video: Dr. Hyo-Soo Kim and Dr. C. Michael Gibson Discuss: Aspirin Vs. Clopidogrel During Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention: The Host Exam Randomized Controlled Trial

 

Commentary on Twitter

 

Expert consensus on peri-operative myocardial injury screening in noncardiac surgery.

18 May, 2021 | 07:12h | UTC

Expert consensus on peri-operative myocardial injury screening in noncardiac surgery: A literature review – European Journal of Anaesthesiology

Invited Commentary: Expert consensus on peri-operative myocardial injury screening in noncardiac surgery

 

#ACC21 – [Not published yet] RCT: DARE-19: Dapagliflozin is safe, but did not significantly improve outcomes among high-risk patients hospitalized with COVID-19.

17 May, 2021 | 08:49h | UTC

DARE-19: Dapagliflozin in High-Risk Patients Hospitalized With COVID-19 – American College of Cardiology

See also: Dapagliflozin in Respiratory Failure in Patients With COVID-19 – DARE-19 – American College of Cardiology

 

Commentaries on Twitter

 

Setting the record straight: There is no ‘Covid heart’.

17 May, 2021 | 08:47h | UTC

Setting the record straight: There is no ‘Covid heart’ – STAT

 

Commentary on Twitter

 

#ACC21 – Practice Changing RCT: In patients with atrial fibrillation (75% maintained on anticoagulation), left atrial appendage occlusion during cardiac surgery reduces the incidence of stroke and systemic embolism (4.8 vs. 7.0%) in the following years.

17 May, 2021 | 08:33h | UTC

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Simple surgery prevents strokes in heart patients – McMaster University AND Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III – TCTMD

Video: The Left Atrial Appendage Occlusion Study (LAAOS) III

 

Commentary on Twitter

 

#ACC21 – RCT: No significant differences in cardiovascular events or major bleeding between patients receiving 81 mg vs. 325 mg of aspirin daily.

17 May, 2021 | 08:31h | UTC

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE – TCTMD AND Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness – ADAPTABLE – American College of Cardiology

Video: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial

 

#ACC21 – RCT: Tailored, earlier heart failure rehabilitation program has physical and emotional benefits for older patients.

17 May, 2021 | 08:23h | UTC

Physical Rehabilitation for Older Patients Hospitalized for Heart Failure – New England Journal of Medicine

Commentaries: Tailored, earlier heart failure rehab has physical, emotional benefits for patients – National institutes of Health AND REHAB-HF: Tailored Cardiac Rehab Program Improved Function and Quality of Life in Older HF Patients – American College of Cardiology AND Rehabilitation Therapy in Older Acute Heart Failure Patients – REHAB-HF – American College of Cardiology

Video: A Novel Physical Rehabilitation Intervention For Older Patients With Acute Decompensated Heart Failure: The REHAB-HF Trial

 

Commentaries on Twitter

 

#ACC21 – RCT: In patients with STEMI undergoing complete revascularization, an FFR-guided strategy did not improve outcomes compared to an angiography-guided strategy.

17 May, 2021 | 08:26h | UTC

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: FLOWER-MI: No Benefit to Multivessel PCI Guided by FFR vs. Angiography For MI – American College of Cardiology

 

#ACC21 – [Not published yet] RCT: PARADISE-MI: Sacubitril/Valsartan did not outperform ACE inhibitor after myocardial infarction with new onset heart failure.

17 May, 2021 | 08:17h | UTC

PARADISE-MI: Sacubitril/Valsartan Did Not Outperform ACE Inhibitor After MI – American College of Cardiology

See also: Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction – PARADISE-MI – American College of Cardiology

 

#ACC21 – [Not published yet] RCT: Among patients undergoing TAVR, full-dose apixaban is not superior to standard of care (vitamin K antagonist if indication for oral anticoagulation; antiplatelet therapy if no indication).

17 May, 2021 | 08:19h | UTC

Anti-Thrombotic Strategy to Lower All cardiovascular and Neurologic Ischemic and Hemorrhagic Events after Trans-Aortic Valve Implantation for Aortic Stenosis – ATLANTIS – American College of Cardiology

Commentaries: ATLANTIS: Apixaban Not Superior to Standard Care After TAVR – American College of Cardiology AND ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI – TCTMD

 

Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.

14 May, 2021 | 08:30h | UTC

Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens – The Lancet Health Longevity

Podcast with the author: Dr Paula Rochon talks with The Lancet Healthy Longevity about polypharmacy in older people through a sex and gender lens

Related: Reducing Inappropriate Medication Use & Polypharmacy (several articles and commentaries on the subject) AND Polypharmacy Management in Older Patients – Mayo Clinic Proceedings AND Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy – Deutsches Ärzteblatt internationa AND Eliminating Medication Overload: A National Action Plan AND Deprescribing in Older Adults With Cardiovascular Disease – Journal of the American College of Cardiology

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.